Request Free Sample ×

Kindly complete the form below to receive a free sample of this Report

* Please use a valid business email

Leading companies partner with us for data-driven Insights

clients tt-cursor
Hero Background

US Egg Allergy Market

ID: MRFR/Pharma/11249-HCR
100 Pages
Satyendra Maurya
April 2026

US Egg Allergy Market Research Report: By Age Group (Children, Adults), By Diagnosis (Skin Test, Blood Test, Food Challenge, others), By Treatment (Medication, Oral Immunotherapy) and By End User (Hospitals, Clinics, Diagnostic Centers, Research Institutes, others) - Growth & Industry Forecast 2025 To 2035

Share:
Download PDF ×

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

US Egg Allergy Market Infographic
Purchase Options

US Egg Allergy Market Summary

As per Market Research Future analysis, the US egg allergy market Size was estimated at 293.05 USD Million in 2024. The US egg allergy market is projected to grow from 314.85 USD Million in 2025 to 645.21 USD Million by 2035, exhibiting a compound annual growth rate (CAGR) of 7.4% during the forecast period 2025 - 2035

Key Market Trends & Highlights

The US egg allergy market is experiencing a notable shift towards egg-free alternatives driven by health consciousness and regulatory changes.

  • The demand for egg-free products is increasing as consumers seek alternatives due to health concerns and allergies.
  • Enhanced regulatory frameworks are shaping the market, ensuring better labeling and safety standards for food products.
  • Plant-based diets are on the rise, contributing to the growth of egg-free options in various food segments.
  • Key market drivers include growing awareness of food allergies and innovation in food technology, which are propelling the market forward.

Market Size & Forecast

2024 Market Size 293.05 (USD Million)
2035 Market Size 645.21 (USD Million)
CAGR (2025 - 2035) 7.44%

Major Players

Nestle (CH), Kraft Heinz (US), General Mills (US), Danone (FR), Unilever (GB), Bunge Limited (US), Cargill (US), Kewpie Corporation (JP), Otsuka Pharmaceutical (JP)

Our Impact
Enabled $4.3B Revenue Impact for Fortune 500 and Leading Multinationals
Partnering with 2000+ Global Organizations Each Year
30K+ Citations by Top-Tier Firms in the Industry

US Egg Allergy Market Trends

The egg allergy market is characterized by a growing awareness of food allergies and their implications for health. As more individuals, particularly children, are diagnosed with egg allergies, the demand for alternative products has surged. This shift is evident in the increasing availability of egg-free options in grocery stores and restaurants. Additionally, educational initiatives aimed at parents and caregivers are becoming more prevalent, helping to inform them about the risks associated with egg allergies and the importance of allergen management. This heightened awareness is likely to drive innovation in product development, as manufacturers seek to create safe and appealing alternatives for those affected. Moreover, regulatory bodies are playing a crucial role in shaping the landscape of the egg allergy market. Stricter labeling requirements and guidelines for allergen management are being implemented, which may enhance consumer confidence in food products. The rise of plant-based diets also contributes to this market, as consumers increasingly seek out substitutes that do not contain eggs. This trend reflects a broader movement towards healthier eating habits and the desire for transparency in food sourcing. As the egg allergy market continues to evolve, it appears poised for further growth, driven by consumer demand for safe, nutritious, and allergen-free options.

Increased Demand for Egg-Free Products

The egg allergy market is witnessing a notable rise in the demand for egg-free alternatives. This trend is largely driven by the growing number of individuals diagnosed with egg allergies, particularly among children. As awareness of food allergies expands, consumers are actively seeking products that do not contain eggs, prompting manufacturers to innovate and diversify their offerings.

Enhanced Regulatory Frameworks

Regulatory bodies are increasingly focusing on food safety and allergen management, which significantly impacts the egg allergy market. Stricter labeling requirements and guidelines are being established to ensure that consumers are well-informed about potential allergens in food products. This regulatory environment fosters greater transparency and consumer trust.

Rise of Plant-Based Diets

The shift towards plant-based diets is influencing the egg allergy market, as more consumers opt for alternatives that exclude animal products. This trend aligns with a broader movement towards healthier eating and sustainability. Manufacturers are responding by developing innovative egg substitutes derived from plant sources, catering to both those with allergies and health-conscious consumers.

US Egg Allergy Market Drivers

Rising Health Consciousness

The growing trend of health consciousness among consumers is impacting the egg allergy market. Many individuals are increasingly aware of the health implications associated with food allergies and intolerances. This awareness has led to a surge in demand for allergen-free products, including those specifically designed for individuals with egg allergies. According to Market Research Future, the health and wellness food sector is expected to grow by approximately 8% annually, indicating a robust market for egg-free alternatives. As consumers prioritize their health and seek out safer food options, the egg allergy market is likely to expand to meet these evolving preferences.

Innovation in Food Technology

Advancements in food technology are playing a crucial role in shaping the egg allergy market. The development of egg substitutes derived from various plant sources, such as aquafaba and flaxseed, indicates a shift towards more inclusive food options. These innovations not only provide alternatives for those with egg allergies but also appeal to a broader audience seeking healthier or vegan choices. The market for egg substitutes is projected to reach approximately $1 billion by 2026, reflecting a growing consumer preference for allergen-free products. As food technology continues to evolve, it is likely that the egg allergy market will benefit from an influx of new products that meet the needs of consumers with dietary restrictions.

Increased Labeling Regulations

The implementation of stricter labeling regulations in the food industry is influencing the egg allergy market. The FDA mandates clear labeling of allergens, including eggs, which helps consumers make informed choices. This regulatory framework not only protects individuals with egg allergies but also encourages manufacturers to create safer products. As a result, the market for egg-free alternatives is expanding, with a notable increase in the availability of allergen-free options in grocery stores. The egg allergy market is likely to see continued growth as consumers become more confident in purchasing products that are clearly labeled and safe for their dietary needs.

Expansion of E-commerce Platforms

The rise of e-commerce platforms is transforming the egg allergy market by providing consumers with greater access to allergen-free products. Online shopping has become increasingly popular, allowing individuals with egg allergies to easily find and purchase specialized products that may not be available in local stores. This shift towards online retail is supported by a growing number of brands that offer direct-to-consumer sales, enhancing convenience for consumers. As e-commerce continues to expand, it is anticipated that the egg allergy market will benefit from increased visibility and accessibility, ultimately leading to higher sales and a broader range of product offerings.

Growing Awareness of Food Allergies

The increasing awareness surrounding food allergies, particularly among parents and caregivers, appears to be a significant driver for the egg allergy market. Educational campaigns and resources provided by healthcare professionals have led to heightened vigilance regarding food ingredients. This awareness is reflected in the rising number of diagnosed cases of egg allergies, which, according to the CDC, affects approximately 2% of children in the US. As more individuals recognize the potential severity of egg allergies, the demand for egg-free alternatives and products specifically designed for those with egg allergies is likely to grow. Consequently, this trend may lead to an expansion of the egg allergy market, as manufacturers respond to consumer needs by developing innovative solutions that cater to this demographic.

Market Segment Insights

By Age Group: Children (Largest) vs. Adults (Fastest-Growing)

In the US egg allergy market, the age group of children holds the largest market share due to the high prevalence of food allergies within this demographic. Many parents are increasingly aware of egg allergies and proactively seek alternatives for their children, leading to a robust consumer base in this segment. On the other hand, adults are emerging as a significant segment as awareness about food allergies increases among older age groups. As adults are discovering food sensitivities, they are now seeking suitable substitutes for eggs in their diets, bolstering their market presence significantly. Growth trends indicate that the market for egg alternatives among adults is rapidly gaining traction, driven by changing dietary preferences and increasing health consciousness. This demographic is exploring various options, such as plant-based substitutes, which are favored for their nutritional benefits and allergen-free profiles. The herculean efforts made by food manufacturers to introduce innovative products tailored for adult consumers with egg allergies are fueling this growth, making it a compelling area of focus for market stakeholders.

Children (Dominant) vs. Adults (Emerging)

Children represent the dominant segment in the US egg allergy market, characterized by a high incidence of diagnosed allergies necessitating careful dietary restrictions. This segment benefits from a strong demand for safe, allergen-free food products, which drives innovation in offerings tailored for children. Conversely, the adult segment is considered emerging, showing a notable upward trajectory as more adults recognize their sensitivities to eggs. This transition is influenced by a broader trend toward health and wellness, with adults actively seeking out egg alternatives to manage their dietary needs effectively. Companies are thus pivoting to develop products that cater to the specific preferences and trends within these demographics, ensuring both segments have a robust foothold in the market.

By Treatment: Egg Allergy Medication (Largest) vs. Oral Immunotherapy (Fastest-Growing)

The US egg allergy market exhibits a significant distribution in treatment modalities, with Egg Allergy Medication commanding the largest share. This segment includes traditional antihistamines and corticosteroids that effectively manage allergic reactions, offering a reliable form of relief and leading the market in adoption rates. In contrast, Oral Immunotherapy, while currently smaller in market share, is rapidly gaining attention for its innovative approach to desensitize individuals to allergens over time. Growth trends indicate that Oral Immunotherapy is at the forefront of advancements in allergy management, attracting both consumer interest and investment. As more clinical research validates its efficacy and safety, demand for this treatment is expanding swiftly. Factors driving growth include increased awareness of egg allergies, advancements in medical research, and the rising shift towards personalized medicine aimed at tailored treatment solutions.

Egg Allergy Medication (Dominant) vs. Oral Immunotherapy (Emerging)

Egg Allergy Medication serves as the dominant treatment option, providing stable and effective short-term relief from allergic reactions. This segment benefits from widespread acceptance among healthcare providers and patients alike, with established manufacturing processes and availability in various forms such as syrups and tablets. On the other hand, Oral Immunotherapy represents an emerging approach that has the potential to transform allergy treatment paradigms. It focuses on gradually increasing exposure to allergens to build long-term tolerance. As patient education and outcomes improve, it is expected to grow rapidly, appealing to those seeking more permanent solutions to their egg allergies.

By Diagnosis: Blood Tests (Largest) vs. Skin Tests (Fastest-Growing)

In the US egg allergy market, the diagnosis segment is primarily dominated by blood tests, which hold a significant share due to their ease of administration and reliability. Blood tests are widely accepted by healthcare professionals and parents alike, contributing to their leading position in the market. Skin tests, while trailing in terms of overall market share, are growing rapidly as they offer quick results and are increasingly favored for their non-invasive nature. The growth of the diagnosis segment is driven by heightened awareness of food allergies and an increase in patient testing rates. Newer diagnostic methodologies are emerging, enhancing the accuracy and efficiency of testing procedures. The rising prevalence of egg allergies, particularly among children, propels demand for both blood and skin tests, as healthcare providers emphasize early diagnosis and management strategies to mitigate allergy-related risks.

Blood Tests (Dominant) vs. Skin Tests (Emerging)

Blood tests remain the dominant diagnostic method in the market, favored for their comprehensive analysis of allergy levels through IgE detection. This technique is highly relied upon for its accuracy, allowing for a better understanding of individual allergy profiles. Conversely, skin tests are emerging as a preferred alternative, especially among pediatric patients, due to their rapid results and minimal discomfort. As healthcare providers increasingly adopt these non-invasive techniques, skin tests are expected to gain traction and evolve further, fostering advancements in allergy diagnostic technologies. Together, these methods play a crucial role in identifying and managing egg allergies effectively.

By End-User: Hospitals and Clinics (Largest) vs. Egg Research and Consultancy (Fastest-Growing)

In the US egg allergy market, Hospitals and Clinics hold the largest share, accounting for a significant portion of the market due to their pivotal role in patient care and treatment. This segment benefits from increased hospital visits owing to allergic reactions, thus solidifying its market presence. On the other hand, Egg Research and Consultancy is emerging as the fastest-growing segment, driven by heightened focus on research and development related to egg allergies and the demand for specialized consultancy services. The growth trends reflect an increasing understanding and management of egg allergies, leading to expanded services in Hospitals and Clinics. Furthermore, the rising number of research initiatives and collaborations in the Egg Research and Consultancy segment highlights the market's evolution. This growth is underpinned by innovation in diagnostic techniques and treatment methodologies, showcasing a dynamic shift towards more specialized care and improved patient outcomes.

Hospitals and Clinics: Dominant vs. Egg Research and Consultancy: Emerging

Hospitals and Clinics provide comprehensive care, including diagnosis and management of egg allergies, which positions them as the dominant players in the US egg allergy market. They are equipped with medical professionals and facilities that cater to immediate health needs, contributing substantially to the market share. Conversely, Egg Research and Consultancy serves as an emerging segment focusing on the advancement of knowledge and practice in allergies. With professionals dedicated to innovative research, this segment is rapidly gaining traction, reflecting the growing demand for expertise in allergy management. Together, these segments shape the landscape of egg allergy care, with Hospitals and Clinics leading in patient treatment while Egg Research and Consultancy enhances the scientific understanding of the condition.

Get more detailed insights about US Egg Allergy Market

Key Players and Competitive Insights

The egg allergy market in the US exhibits a dynamic competitive landscape characterized by a blend of innovation, strategic partnerships, and a focus on consumer health. Key players such as Kraft Heinz (US), General Mills (US), and Unilever (GB) are actively shaping the market through their distinct operational strategies. Kraft Heinz (US) emphasizes product reformulation to cater to allergen-sensitive consumers, while General Mills (US) focuses on expanding its portfolio of allergen-free products. Unilever (GB), on the other hand, is investing in sustainable sourcing and transparency in its supply chain, which resonates well with health-conscious consumers. Collectively, these strategies not only enhance their market positioning but also contribute to a more competitive environment that prioritizes consumer safety and product innovation.In terms of business tactics, companies are increasingly localizing manufacturing to reduce supply chain vulnerabilities and enhance responsiveness to market demands. The competitive structure of the egg allergy market appears moderately fragmented, with several players vying for market share. However, the influence of major companies is substantial, as they leverage their resources to optimize supply chains and innovate product offerings. This collective effort by key players fosters a competitive atmosphere that encourages continuous improvement and adaptation to consumer needs.

In October Kraft Heinz (US) announced a partnership with a leading food technology firm to develop plant-based egg alternatives aimed at consumers with egg allergies. This strategic move is significant as it not only diversifies their product line but also positions them at the forefront of the growing demand for allergen-free alternatives. By investing in innovative food technologies, Kraft Heinz (US) is likely to enhance its competitive edge in a market that increasingly values health and safety.

In September General Mills (US) launched a new line of allergen-free baking mixes, which are specifically designed for consumers with egg allergies. This initiative reflects the company's commitment to inclusivity in food products and addresses a significant gap in the market. The introduction of these mixes is expected to attract a broader consumer base, thereby strengthening General Mills' market presence and reinforcing its reputation as a leader in allergen-free solutions.

In August Unilever (GB) unveiled a new sustainability initiative aimed at reducing allergen cross-contamination in its production facilities. This initiative is crucial as it not only enhances product safety but also aligns with the growing consumer demand for transparency and ethical practices in food production. By prioritizing sustainability, Unilever (GB) is likely to foster greater consumer trust and loyalty, which are essential in a market where health concerns are paramount.

As of November current trends in the egg allergy market indicate a strong shift towards digitalization, sustainability, and the integration of AI in product development and supply chain management. Strategic alliances among companies are increasingly shaping the competitive landscape, allowing for shared resources and knowledge that drive innovation. Looking ahead, it appears that competitive differentiation will evolve from traditional price-based strategies to a focus on innovation, technological advancements, and reliable supply chains. This shift underscores the importance of adapting to consumer preferences and regulatory demands in a rapidly changing market.

Key Companies in the US Egg Allergy Market include

Industry Developments

In the US Egg Allergy Market, recent developments have focused on the growing demand for allergen-free products and alternatives. Companies such as Just and Beyond Meat have gained traction for their plant-based egg substitutes, appealing to consumers seeking egg-free options. The market has been influenced by an increasing awareness of food allergies, particularly among children. As of October 2023, Kraft Heinz announced a partnership with Ripple Foods to expand its allergen-friendly product offerings, reflecting a trend toward strategic collaborations in the industry.

The valuation of companies involved in egg alternatives has seen significant growth, driven by consumer preferences for healthier and safer food options. In the past few years, notable events such as the acquisition of Oatly by a major investment firm in July 2022 have positioned it to further capitalize on the dairy alternative segment, influencing the broader market dynamics. The US government has also prioritized food allergy education and awareness initiatives, reinforcing the importance of safe food practices and underscoring the need for innovative products in the market.

Companies like Unilever and Nestle are expected to explore further investments in allergen-free innovations to meet rising consumer demands.

Future Outlook

US Egg Allergy Market Future Outlook

The Egg Allergy Market is projected to grow at a 7.44% CAGR from 2025 to 2035, driven by increasing awareness and innovative treatment options.

New opportunities lie in:

  • Development of specialized egg-free food products for allergic consumers.
  • Investment in advanced diagnostic tools for early egg allergy detection.
  • Expansion of educational programs for healthcare professionals on egg allergies.

By 2035, the market is expected to achieve substantial growth, reflecting evolving consumer needs and enhanced product offerings.

Market Segmentation

US Egg Allergy Market End-User Outlook

  • Hospitals and Clinics
  • Egg Research and Consultancy
  • Diagnostics Centers

US Egg Allergy Market Age Group Outlook

  • Children
  • Adults

US Egg Allergy Market Diagnosis Outlook

  • Blood Tests
  • Skin Tests
  • Others

US Egg Allergy Market Treatment Outlook

  • Egg Allergy Medication
  • Oral Immunotherapy

Report Scope

MARKET SIZE 2024 293.05(USD Million)
MARKET SIZE 2025 314.85(USD Million)
MARKET SIZE 2035 645.21(USD Million)
COMPOUND ANNUAL GROWTH RATE (CAGR) 7.44% (2025 - 2035)
REPORT COVERAGE Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
BASE YEAR 2024
Market Forecast Period 2025 - 2035
Historical Data 2019 - 2024
Market Forecast Units USD Million
Key Companies Profiled Nestle (CH), Kraft Heinz (US), General Mills (US), Danone (FR), Unilever (GB), Bunge Limited (US), Cargill (US), Kewpie Corporation (JP), Otsuka Pharmaceutical (JP)
Segments Covered Age Group, Treatment, Diagnosis, End-User
Key Market Opportunities Growing demand for allergen-free products presents opportunities in the egg allergy market.
Key Market Dynamics Rising consumer awareness drives demand for egg-free alternatives, influencing product innovation and market competition.
Countries Covered US
Author
Author
Author Profile
Satyendra Maurya LinkedIn
Research Analyst
An accomplished research analyst with high proficiency in market forecasting, data visualization, competitive benchmarking, and others. He holds a pronounced track record in research and consulting projects for sectors such as life sciences, medical devices, and healthcare IT. His capabilities in qualitative and quantitative analysis have resulted in positive client outcomes. Working on niche market trends, opportunities, sales, and forecasted value is part of his skill set.
Co-Author
Co-Author Profile
Garvit Vyas LinkedIn
Vice President - Operations
Garvit Vyas is a Research Analyst with experience in working across multiple industry domains in the market research sector. Over the past four years, he has been actively involved in analyzing diverse markets, gathering industry insights, and contributing to the development of comprehensive research reports. His work includes studying market trends, evaluating competitive landscapes, and supporting data-driven business insights. In the early phase of his career, Garvit worked on cross-domain research projects, which helped him build a strong foundation in market analysis, data interpretation, and industry intelligence across various sectors. Later, he transitioned into the Quality Control (QC) function, where he focuses on reviewing and refining research reports and marketing collaterals to ensure accuracy, consistency, and high editorial standards. His responsibilities include validating research data, improving report structure, and maintaining the overall quality of published content. Garvit is committed to maintaining strong research integrity and delivering reliable insights that support informed business decision-making.
Leave a Comment

FAQs

What was the market valuation of the US egg allergy market in 2024?

The market valuation of the US egg allergy market was $293.05 Million in 2024.

What is the projected market valuation for the US egg allergy market by 2035?

The projected market valuation for the US egg allergy market is $645.21 Million by 2035.

What is the expected CAGR for the US egg allergy market during the forecast period 2025 - 2035?

The expected CAGR for the US egg allergy market during the forecast period 2025 - 2035 is 7.44%.

Which age group had a higher market valuation in 2024 for egg allergy treatments?

In 2024, the adult age group had a higher market valuation of $193.05 Million compared to $100.0 Million for children.

What are the two main treatment segments for egg allergies and their valuations in 2024?

The two main treatment segments for egg allergies in 2024 were egg allergy medication at $150.0 Million and oral immunotherapy at $143.05 Million.

What was the market valuation for blood tests in the diagnosis segment in 2024?

The market valuation for blood tests in the diagnosis segment was $70.0 Million in 2024.

Which end-user segment had the highest valuation in 2024?

In 2024, the diagnostics centers segment had the highest valuation at $113.05 Million among end-users.

Who are the key players in the US egg allergy market?

Key players in the US egg allergy market include Nestle, Kraft Heinz, General Mills, Danone, Unilever, Bunge Limited, Cargill, Kewpie Corporation, and Otsuka Pharmaceutical.

What was the valuation for skin tests in the diagnosis segment in 2024?

The valuation for skin tests in the diagnosis segment was $50.0 Million in 2024.

What is the projected growth trend for the US egg allergy market from 2025 to 2035?

The US egg allergy market is projected to experience growth, reaching $645.21 Million by 2035, indicating a robust upward trend.

Download Free Sample

Kindly complete the form below to receive a free sample of this Report

Compare Licence

×
Features License Type
Single User Multiuser License Enterprise User
Price $4,950 $5,950 $7,250
Maximum User Access Limit 1 User Upto 10 Users Unrestricted Access Throughout the Organization
Free Customization
Direct Access to Analyst
Deliverable Format
Platform Access
Discount on Next Purchase 10% 15% 15%
Printable Versions
%>